Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Alessandra Pivetti

1PUBLICATIONS
21CO-AUTHORS
Liquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Feb 07, 2023
Feasibility, safety, and outcome of second-line nivolumab/bevacizumab in liver transplant patients with recurrent hepatocellular carcinoma.

Lorenza Di Marco, Alessandra Pivetti, Francesco Giuseppe Foschi

Pageof 1

Frequent Collaborators

1 joint publications

Lorenza Di Marco

1 joint publications

Francesco Giuseppe Foschi

1 joint publications

Roberto D'Amico

1 joint publications

Filippo Schepis

1 joint publications

Cristian Caporali

1 joint publications

Federico Casari

1 joint publications

Simone Lasagni

1 joint publications

Rosina Maria Critelli

1 joint publications

Fabiola Milosa

1 joint publications

Adriana Romanzi

Frequent Collaborators

1 joint publications

Lorenza Di Marco

1 joint publications

Francesco Giuseppe Foschi

1 joint publications

Roberto D'Amico

1 joint publications

Filippo Schepis

Top Related Videos

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on : May 24, 2024

541
See more related videos

Top Related Videos

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on : May 24, 2024

541
See more related videos